Alcon AG | ALC - Ativos





Ativos Alterar Data
AstraZeneca USD 119.92B 4.09B 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Essilor EUR 65.06B 1.16B 2026-06
Fresenius EUR 42.24B 401M 2026-09
Fresenius Medical Care EUR 31.45B 155.97M 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
GRIFOLS EUR 20.28B 191M 2026-09
Lonza CHF 18.97B 164M 2025-12
Merck EUR 52.69B 383M 2026-06
Novartis USD 117.15B 4.88B 2026-09
Philips EUR 28.03B 1.33B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
Smith & Nephew USD 11.01B 321M 2026-06
Sonova Holding CHF 5.92B 468.2M 2025-06
UCB EUR 18.16B 971M 2025-12